No labels on samosa or jalebi: Health ministry issues clarification on healthy eating advisory

The Union Health Ministry has clarified that its recent advisory urging workplaces to display Oil and Sugar Boards is aimed at promoting healthier eating habits and greater public awareness about hidden fats and excess sugar in foods. The Ministry has dismissed recent media reports claiming that it has mandated Warning Labels on food items like samosa, jalebi and laddoo, calling such reports misleading and incorrect.

The advisory recommends that workplaces such as office lobbies, canteens, cafeterias and meeting rooms install boards that highlight the health risks associated with excessive consumption of oil and sugar. According to the Ministry, these boards act as behavioural nudges to encourage individuals to make healthier dietary choices in daily life, especially as the country sees a sharp rise in obesity and related lifestyle diseases.

Officials have underlined that the advisory is not about targeting specific Indian snacks or street food. Instead, it aims to promote general awareness about hidden fats and sugars across all food categories. The Ministry has further clarified that it has not directed vendors or manufacturers to carry warning labels on food products.

As part of the broader message, the advisory also encourages workplaces to promote healthier meal options such as fruits, vegetables and low-fat foods. It suggests practical steps to incorporate physical activity into daily routines — including use of stairs, short exercise breaks during work hours and creating walking routes within office campuses.

The initiative is part of the Union Health Ministry’s flagship programme — the National Programme for Prevention and Control of Non Communicable Diseases (NP-NCD). Experts highlight that excessive consumption of oil and sugar significantly contributes to rising rates of obesity, diabetes, hypertension and other non-communicable diseases across the country.

RELATED ARTICLES

6 hours ago | genetic cholesterol target

Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target

The recent failure of a Novartis Sexperimental heart drug in a large trial raised questions among cardiologists and investors about the widely held idea that reducing levels of a genetically set cholesterol carrier called lipoprotein(a) can improve h...

6 hours ago | Alpha-Synuclein

Rare case of early-onset Parkinson’s reveals platelet changes, indicating disease progression

A study of a rare case early-onset Parkinson's disease has revealed molecular changes in platelets, suggesting the potential of the blood's smallest component in indicating a progression of the neurodegenerative disorder. The study, published in the...

01/11/26 | 9:27 am | Africa CDC

Global alarm as Ebola spreads from Africa to Europe

Could Ebola become a global health emergency reminiscent of COVID-19? A catastrophic outbreak originating in the Democratic Republic of Congo has crossed a grim milestone, raising alarm far beyond the African continent. Top health officials are now w...